Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MYR

Explore full profile

Biotech company developing and commercialising novel therapies for chronic hepatitis D

Bad Homburg, GermanyFounded 2011Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2020
Headcount <100 Current team size
Total funding $0–10M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for MYR and the history behind them.

About MYR

MYR GmbH, a subsidiary of Gilead Sciences, Inc., is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for areas with significant unmet medical needs. The company operates in the global healthcare market, providing advanced therapeutic solutions to patients with life-threatening illnesses. MYR GmbH primarily serves healthcare providers, hospitals, and patients, leveraging its research and development capabilities to bring new treatments to market. The business model revolves around the development and commercialization of proprietary drugs, generating revenue through the sale of these medicines. By focusing on innovation and patient care, MYR GmbH aims to transform and simplify medical treatment for severe health conditions.

Source: Dealroom company data

At a glance

Founded
2011
Headquarters
Bad Homburg, Germany
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Latest news

Press, funding announcements and product moves mentioning MYR.

See all news

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A1 investor entered at this stage

  • Joint Journey

Series B and later2 investors entered at this stage

  • INSERM
  • University of Heidelberg

Talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇩🇪 Germany · Bad Homburg HQ
Book a demo for the full country breakdown
Web traffic by country
300 monthly visits
across markets
🇨🇦 Canada100%
Top 1 markets shown

Patents

Estimated portfolio value
$4M

2 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MYR on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MYR on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles